Analyst Price Targets — LPTX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 14, 2024 6:08 am | Swayampakula Ramakanth | H.C. Wainwright | $5.50 | $2.83 | TheFly | Leap Therapeutics price target lowered to $5.50 from $7 at H.C. Wainwright |
Latest News for LPTX
Leap Therapeutics (NASDAQ:LPTX) vs. Panbela Therapeutics (OTCMKTS:PBLA) Head-To-Head Analysis
Leap Therapeutics (NASDAQ: LPTX - Get Free Report) and Panbela Therapeutics (OTCMKTS:PBLA - Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Volatility and Risk Leap Therapeutics has a
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for LPTX.
Senate Trading
No Senate trades found for LPTX.
U.S. House Trading
No House trades found for LPTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.